Dailypharm Live Search Close

¡®Hypertension¡¤hyperlipidemia generics are pricier in KOR'

By Lee, Jeong-Hwan | translator Kang, Shin-Kook

24.06.26 05:19:55

°¡³ª´Ù¶ó 0
¡°For 20 or more simultaneously listed same-ingredient generics, price should be set at 85% of the lowest drug price"

MOHW reveals results through the final report on measures to improve the generic drug pricing system


According to a government study, generic drugs for some indications, such as those for the gastrointestinal system, hypertension, and hyperlipidemia, are more expensive in Korea than in major overseas countries other than the United States, such as the United Kingdom, Switzerland, and Japan. As of 2022, Korean generic hyperlipidemia drugs were more than 10 times more expensive than those in the UK and 3 times more expensive than those in Japan, while those for hypertension were 2 times more expensive than those in the UK and 3 times more expensive than those in Japan.

Based on such findings, the study concluded that the government may directly reduce the price of hypertension and hyperlipidemia drugs w

Lee, Jeong-Hwan(junghwanss@dailypharm.com)
If you want to see the full article, please JOIN US (click)